Skip to main content

Advertisement

Fig. 1 | Clinical Proteomics

Fig. 1

From: Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma

Fig. 1

Serum specimens from 62 ND MM and 64 HCs were used for SNN model blind validation. 58 cases of MM were correctly assigned to MM group (93.55% sensitivity). 59 HCs were correctly identified as the non-diseased, 5 cases had been wrongly judged as MM (92.19% specificity). Green circle: HCs; Red cross: MM ND patients; Black dot: MM ND patients in validation group; Blue dot: HCs in validation group

Back to article page